(Q30785119)

26 June 2017

A human SARS-CoV neutralizing antibody against epitope on S2 protein (English)

1 reference

26 June 2017

0 references

1 reference

1 reference

Jinzhu Duan

1

1 reference

26 June 2017

Xiyun Yan

2

1 reference

26 June 2017

Xueming Guo

3

1 reference

26 June 2017

Wuchun Cao

4

1 reference

26 June 2017

Wei Han

5

1 reference

26 June 2017

Cai Qi

6

1 reference

26 June 2017

Jing Feng

7

1 reference

26 June 2017

Dongling Yang

8

1 reference

26 June 2017

Guangxia Gao

9

1 reference

26 June 2017

Gang Jin

10

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Biochemical and Biophysical Research Communications

26 June 2017

1 reference

26 June 2017

333

1 reference

26 June 2017

1

1 reference

26 June 2017

186-193

1 reference

SARS: what have we learned?

26 June 2017

1 reference

12 December 2020

SARS coronavirus: a new challenge for prevention and therapy

1 reference

12 December 2020

The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot.

1 reference

12 December 2020

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

1 reference

12 December 2020

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

1 reference

12 December 2020

A definitive set of oligonucleotide primers for amplifying human V regions

1 reference

12 December 2020

Profile of specific antibodies to the SARS-associated coronavirus.

1 reference

12 December 2020

Exploiting recombination in single bacteria to make large phage antibody libraries

1 reference

12 December 2020

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

12 December 2020

Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

1 reference

12 December 2020

Probing the structure of the SARS coronavirus using scanning electron microscopy

1 reference

12 December 2020

Use of convalescent plasma therapy in SARS patients in Hong Kong.

1 reference

12 December 2020

Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein

1 reference

12 December 2020

Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein

1 reference

12 December 2020

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

A label-free multisensing immunosensor based on imaging ellipsometry.

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies

1 reference

12 December 2020

Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain

1 reference

12 December 2020

Characterization of murine coronavirus neutralization epitopes with phage-displayed peptides

1 reference

12 December 2020

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

1 reference

12 December 2020

Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development

1 reference

12 December 2020

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

1 reference

12 December 2020

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Real time analysis of antibody-antigen reaction kinetics

1 reference

12 December 2020

Protein absorption and ellipsometry in biomaterial research.

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

10.1016/J.BBRC.2005.05.089

Identifiers

DOI

1 reference

26 June 2017

0 references

1 reference